Form 4 for AORT ARTIVION, INC.
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0000784199-23-000163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-19 | 2023-12-15 | AORT | Horton Amy | VP, CAO | S - Sale+OE | $19.00 | -14.4K | 124.0K | -10% | -$273.5K |
| D | 2023-12-19 | 2023-12-15 | AORT | Horton Amy | VP, CAO | M - OptEx | $16.30 | +14.4K | 138.4K | +12% | +$234.7K |
| D | 2023-12-19 | 2023-12-15 | AORT | Horton Amy | VP, CAO | M - OptEx | $16.30 | -14.4K | 0 | -100% | -$234.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | S | D | 14,397 | $19.00 | 124,040 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023. (F2) Reflects the price the shares were sold. |
| 2 | Common | Common Stock | 2023-12-15 | M | A | 14,397 | $16.30 | 138,437 | D | — | — | (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-12-15 | M | D | 14,397 | $16.30 | 0 | D | $16.30 · 2018-02-21 to 2024-02-21 | 14,397 Common Stock | (F3) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. |